Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea
Helicobacter Sep 25, 2017
Kim SY, et al. - Objectives of this study were to compare the efficacy of sequential and concomitant therapies as for the first-line treatments for Helicobacter pylori (H. pylori) eradication and to examine the impacts of clarithromycin resistance on the eradication rates. For H. pylori eradication, concomitant therapy was superior to sequential therapy as the first-line treatment, particularly in clarithromycin-resistant strains in Korea.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries